missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SIGLEC6 (aa 53-176) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (49%), Rat (49%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-82620 (PA5-82620. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
SIGLEC9 (Sialic acid-binding Ig-like lectin 9) is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. It contains two Ig-like C2 type (immunoglobulin-like) domains and one Ig-like V-type (immunoglobulin-like) domain. It preferentially binds to alpha2, 3-or alpha2, 6-linked sialic acid. The sialic acid recognition site may be mased by cis interactions with sialic acids on the same cell surface.
Specifications
Specifications
| Accession Number | O43699 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 946 |
| Name | Human SIGLEC6 (aa 53-176) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | CD327; CD33 antigen-like 1; CD33L; CD33L1; CD33L2; CDW327; OBBP1; OB-BP1; obesity-binding protein 1; sialic acid binding Ig like lectin 6; sialic acid binding Ig-like lectin 6; sialic acid-binding Ig-like lectin 6; Siglec; SIGLEC6; Siglec-6 |
| Common Name | SIGLEC6 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction